{"id":"https://openalex.org/W4388072325","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1351","title":"1351 Identifying IL-27 dependent biomarkers in lymphocytes, NK cells, and myeloid cells in peripheral blood and the tumor microenvironment","display_name":"1351 Identifying IL-27 dependent biomarkers in lymphocytes, NK cells, and myeloid cells in peripheral blood and the tumor microenvironment","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388072325","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1351"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1351","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1351","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1351","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A1505.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A1505.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024081264","display_name":"Karin Golan","orcid":"https://orcid.org/0000-0003-1091-8520","observed_orcids":["https://orcid.org/0000-0003-1091-8520"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karin Golan","raw_affiliation_strings":["Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012423011","display_name":"Ricard Masia","orcid":"https://orcid.org/0000-0002-8248-7195","observed_orcids":["https://orcid.org/0000-0002-8248-7195"]},"institutions":[{"id":"https://openalex.org/I4210100603","display_name":"Coherus BioSciences (United States)","ror":"https://ror.org/00mjj2d85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100603"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ricard Masia","raw_affiliation_strings":["Coherus BioSciences, Inc., Redwood City, CA, USA","Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coherus BioSciences, Inc., Redwood City, CA, USA","institution_ids":["https://openalex.org/I4210100603"]},{"raw_affiliation_string":"Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100548936","display_name":"Yue Ren","orcid":"https://orcid.org/0009-0004-7449-5410","observed_orcids":["https://orcid.org/0009-0004-7449-5410"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yue Ren","raw_affiliation_strings":["Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014592300","display_name":"Yu Yang","orcid":"https://orcid.org/0009-0004-2866-8210","observed_orcids":["https://orcid.org/0009-0004-2866-8210"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu Yang","raw_affiliation_strings":["Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066220779","display_name":"Benjamin H. Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin H Lee","raw_affiliation_strings":["Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026760473","display_name":"Vito J. Palombella","orcid":"https://orcid.org/0009-0004-2939-7053","observed_orcids":["https://orcid.org/0009-0004-2939-7053"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vito J Palombella","raw_affiliation_strings":["Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080920157","display_name":"Jonathan A. Hill","orcid":"https://orcid.org/0000-0002-6052-3052","observed_orcids":["https://orcid.org/0000-0002-6052-3052"]},"institutions":[{"id":"https://openalex.org/I4210100603","display_name":"Coherus BioSciences (United States)","ror":"https://ror.org/00mjj2d85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100603"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan A Hill","raw_affiliation_strings":["Coherus BioSciences, Inc., Redwood City, CA, USA","Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coherus BioSciences, Inc., Redwood City, CA, USA","institution_ids":["https://openalex.org/I4210100603"]},{"raw_affiliation_string":"Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1505","last_page":"A1505"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.48339998722076416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.48339998722076416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.25609999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.2134999930858612,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-27","display_name":"IL-27","score":0.9300000071525574},{"id":"https://openalex.org/keywords/interferon-response-genes","display_name":"interferon response genes","score":0.609000027179718},{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.6909999847412109},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.6570000052452087},{"id":"https://openalex.org/keywords/t-cells","display_name":"T cells","score":0.8809999823570251},{"id":"https://openalex.org/keywords/monocytes","display_name":"monocytes","score":0.7360000014305115},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.800000011920929},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.7210000157356262},{"id":"https://openalex.org/keywords/gbp5","display_name":"GBP5","score":0.9800000190734863},{"id":"https://openalex.org/keywords/irf-1","display_name":"IRF1","score":0.9959999918937683},{"id":"https://openalex.org/keywords/mx2","display_name":"MX2","score":0.5199999809265137},{"id":"https://openalex.org/keywords/socs1","display_name":"SOCS1","score":0.7609999775886536},{"id":"https://openalex.org/keywords/cxcl9","display_name":"CXCL9","score":0.7900000214576721},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6539999842643738},{"id":"https://openalex.org/keywords/cancer-treatment-resistance","display_name":"cancer therapy resistance","score":0.4480000138282776}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6452945470809937},{"id":"https://openalex.org/C32300475","wikidata":"https://www.wikidata.org/wiki/Q18027992","display_name":"IRF1","level":4,"score":0.5615508556365967},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.5388422012329102},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5361475944519043},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5199533700942993},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.517649233341217},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5127488374710083},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4727771282196045},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4222238063812256},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.24911153316497803},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11790913343429565},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.1351","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1351","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1351","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A1505.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:a3a6f23fedec436288bbf68f16c6d31d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/a3a6f23fedec436288bbf68f16c6d31d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1351","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1351","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1351","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A1505.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388072325.pdf","grobid_xml":"https://content.openalex.org/works/W4388072325.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3213229732","https://openalex.org/W4308396321","https://openalex.org/W2890722786","https://openalex.org/W2584078793","https://openalex.org/W4404064184","https://openalex.org/W2166432517","https://openalex.org/W2193297874","https://openalex.org/W3095874142","https://openalex.org/W1522953087","https://openalex.org/W2616836042"],"abstract_inverted_index":{"Background":[0],"Interleukin":[1],"(IL)-27":[2],"is":[3,69],"a":[4,18,255],"heterodimeric":[5],"cytokine":[6,261],"that":[7,68,306],"alters":[8],"the":[9,30,316,328,339,353,365,390,405],"expression":[10,203,217,233,265],"of":[11,20,27,92,127,218,266,324,379,394],"immunoregulatory":[12],"receptors":[13],"and":[14,22,55,75,96,129,134,140,148,165,169,178,183,198,220,224,231,239,246,252,263,280,344,351,371,383,398],"inflammatory":[15],"cytokines":[16,149],"on":[17,119,268,300],"variety":[19],"lymphoid":[21],"myeloid":[23,184,296],"cell":[24,53,57,156,208,381],"types.":[25,209],"Inhibition":[26],"IL-27":[28,108,128,168,199,212,251,285,345,359,395],"with":[29,46,79,107,274,311,319,361,404],"anti-IL-27":[31,406],"antibody,":[32],"CHS-388":[33,408],"(casdozokitug":[34],"or":[35,109],"casdozo;":[36],"formerly":[37],"SRF388),":[38],"has":[39],"shown":[40],"monotherapy":[41],"anti-tumor":[42],"activity":[43,375],"in":[44,71,136,206,222,234,249,286,295,315,327,396,401],"patients":[45,402],"solid":[47],"tumors":[48,397],"including":[49],"PD-1":[50],"experienced":[51],"renal":[52],"carcinoma":[54],"non-small":[56],"lung":[58],"cancer":[59,80],"(NSCLC).":[60],"We":[61],"previously":[62],"characterized":[63],"an":[64,374],"IL-27-induced":[65,87],"gene":[66,88,202],"signature":[67],"enriched":[70],"interferon":[72],"(IFN)-responsive":[73],"genes":[74,192,290],"known":[76],"to":[77,90,124,162,167,215,229,244,258,357,367,377],"associate":[78],"therapy":[81],"resistance.":[82],"Here":[83],"we":[84],"directly":[85],"compared":[86],"transcription":[89],"those":[91],"type":[93,97,362],"1":[94,363],"(IFN\u03b1/IFN\u03b2)":[95],"2":[98],"(IFN\u03b3)":[99],"IFNs.":[100,170],"Methods":[101],"Anti-CD3":[102],"activated":[103],"human":[104,137],"PBMCs":[105,159],"treated":[106,403],"IFNs":[110,197,343,364],"were":[111,143,150,160,193],"analyzed":[112],"by":[113,145,152,195,284,293],"single":[114],"-cell":[115],"RNA":[116],"sequencing.":[117],"Immunohistochemistry":[118],"sequential":[120],"samples":[121,304],"was":[122,204],"used":[123],"assess":[125],"co-localization":[126],"its":[130],"receptor":[131],"IL-27RA,":[132],"PD-L1,":[133],"GBP5":[135,139,219,279],"tumors.":[138],"IRF1":[141,221,281],"levels":[142],"measured":[144],"flow":[146],"cytometry":[147],"quantified":[151],"ELISA.":[153],"Results":[154],"Immune":[155],"subpopulations":[157],"from":[158],"found":[161],"differentially":[163],"express":[164,175,186],"respond":[166],"After":[171],"activation,":[172],"pDCs":[173],"transiently":[174],"IFN\u03b1/IFN\u03b2,":[176],"T":[177,223,235,269,369],"NK":[179,225,237,372],"cells":[180,185,350,370],"produce":[181],"IFN\u03b3,":[182,358],"IL-27.":[187],"Although":[188],"many":[189],"canonical":[190],"IFN-responsive":[191],"induced":[194],"both":[196],"treatment,":[200],"biased":[201],"observed":[205],"different":[207,348],"For":[210],"example,":[211],"stimulation":[213],"led":[214,228,243],"differential":[216],"cells;":[226],"IFN\u03b2":[227],"IFIT1":[230],"MX2":[232],"cells,":[236,238,270,288,322,373],"monocytes;":[240],"while":[241],"IFN\u03b3":[242,275,294],"SOCS1":[245],"CXCL9":[247],"upregulation":[248],"monocytes.":[250],"IFN\u03b1/IFN\u03b2":[253],"share":[254],"similar":[256],"ability":[257,366],"inhibit":[259],"pro-inflammatory":[260],"secretion":[262],"increase":[264],"PD-L1":[267],"functions":[271],"not":[272],"evident":[273],"stimulation.":[276],"Interestingly,":[277],"although":[278],"are":[282,291,309],"elevated":[283],"T/NK":[287],"these":[289],"augmented":[292],"cells.":[297],"Finally,":[298],"immunohistochemistry":[299],"treatment-na\u00efve":[301],"NSCLC":[302,329],"patient":[303],"showed":[305],"IL-27+":[307],"macrophages":[308],"co-localized":[310],"GBP5+":[312],"T-cell-rich":[313],"areas":[314],"TME":[317],"along":[318],"PD-L1+":[320],"immune":[321,340,349,391],"suggestive":[323],"IL-27-dependent":[325],"signaling":[326,346],"tumor":[330],"microenvironment":[331],"(TME).":[332],"Conclusions":[333],"These":[334,385],"studies":[335],"lend":[336],"insights":[337],"into":[338],"interplay":[341],"between":[342],"across":[347],"within":[352],"TME.":[354],"In":[355],"contrast":[356],"shares":[360],"modulate":[368],"ascribed":[376],"mechanisms":[378,393],"effector":[380],"regulation":[382],"exhaustion.":[384],"observations":[386],"will":[387],"help":[388],"inform":[389],"suppressive":[392],"biomarker":[399],"exploration":[400],"antibody":[407],"(casdozokitug).":[409]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}